Search Within

Joachim Yahalom

  1. "Pediatrics, Department of"
Formats
  1. Meeting Abstract (8)
  2. Journal Article (6)
  3. Conference Paper (1)
Groups
  1. Department of Medicine (15)
  2. Pediatrics, Department of (15)
  3. Radiation Oncology, Department of (15)
  4. Survivorship Research (15)
  5. Hematologic Malignancies, Division of (14)
  6. Center for Hematologic Malignancies (13)

More Groups

People
  1. Richard O'Reilly (8)
  2. Craig Moskowitz (7)
  3. David Straus (7)
  4. Andrew Zelenetz (6)
  5. Carol Portlock (6)
  6. Nancy Kernan (6)

More People

Years
  1. 2024 (1)
  2. 2016 (1)
  3. 2015 (1)
  4. 2013 (1)
  5. 2010 (1)
  6. 2003 (1)

More Years

Publications
  1. Blood (7)
  2. International Journal of Radiation Oncology, Biology, Physics (2)
  3. Biology of Blood and Marrow Transplantation (1)
  4. British Journal of Haematology (1)
  5. Haematologica (1)
  6. Lancet Oncology (1)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. Elsevier Inc. (4)
  3. American Association for Cancer Research (1)
  4. Elsevier Science, Inc. (1)
  5. Ferrata Storti Foundation (1)
  6. John Wiley & Sons (1)

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A proof-of-principle study of split-course bridging radiotherapy (SC-BRT) prior to commercial CAR T-cell therapies for relapsed or refractory B-cell lymphomas: Results from phase 1a pilot cohort
    Meeting Abstract

    Imber, B. S.; Palomba, M. L.; Brosoff, A.; Roszak, E.; McAvoy, D.; Hosszu, K.; Boardman, A.; Dahi, P. B.; Lin, R. J.; Shah, G. L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • PET-adapted therapy with brentuximab vedotin and augmented ICE for relapsed/refractory Hodgkin lymphoma - Lack of Improvement with 3 versus 2 cycles of weekly brentuximab vedotin
    Meeting Abstract

    Moskowitz, A. J.; Schòˆder, H.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: A non-randomised, open-label, single-centre, phase 2 study
    Journal Article

    Moskowitz, A. J.; Schòˆder, H.; Yahalom, J.; Mccall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: Long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease
    Journal Article

    Goldberg, J. D.; Linker, A.; Kuk, D.; Ratan, R.; Jurcic, J.; Barker, J. N.; Castro-Malaspina, H.; Giralt, S.; Hsu, K.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging: Research paper
    Journal Article

    Moskowitz, C. H.; Yahalom, J.; Zelenetz, A. D.; Zhang, Z.; Filippa, D.; Teruya-Feldstein, J.; Kewalramani, T.; Moskowitz, A. J.; Rice, R.; Maragulia, J.; more...
    British Journal of Haematology (2010)

    Fulltext@MSK | Save
  • Risk-adpated high dose chemoradiotherapy and ASCT for patients with relapsed and primary refractory Hodgkin's disease: An intent to treat analysis
    Meeting Abstract

    Moskowitz, C. H.; Kewalramani, T.; Nimer, S. D.; Rice, R. D.; Rosenzweig, L.; Horwitz, S.; Noy, A.; O'connor, O.; Portlock, C. S.; Straus, D.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: Analysis by intent to treat and development of a prognostic model
    Journal Article

    Moskowitz, C. H.; Nimer, S. D.; Zelenetz, A. D.; Trippett, T.; Hedrick, E. E.; Filippa, D. A.; Louie, D.; Gonzales, M.; Walits, J.; Coady-Lyons, N.; more...
    Blood (2001)

    Fulltext@MSK | Save
  • T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: Freedom from relapse in the absence of graft-versus-host disease
    Journal Article

    Papadopoulos, E. B.; Carabasi, M. H.; Castro-Malaspina, H.; Childs, B. H.; Mackinnon, S.; Boulad, F.; Gillio, A. P.; Kernan, N. A.; Small, T. N.; Szabolcs, P.; more...
    Blood (1998)

    Fulltext@MSK | Save
  • Ifosfamide (I), carboplatin (C) and etoposide (E) (ICE) cytoreduction followed by high dose chemoradiotherapy and ASCT for refractory and relapsed Hodgkin's disease (HD): An intent to treat study
    Meeting Abstract

    Moskowitz, C. H.; Nimer, S. D.; Portlock, C. S.; Straus, D. J.; Pearse, R.; O'Brien, J. P.; Berger, M.; Gardner, S.; Trippett, T. M.; Zelenetz, A. D.; more...
    Blood (1997)

    Fulltext@MSK | Save
  • Allogeneic bone marrow transplantation (allo-BMT) or autologous BMT (ABMT) for the treatment of pediatric patients with non-Hodgkin's lymphoma (NHL)
    Meeting Abstract

    Boulad, F.; Gillio, A.; Gardner, S.; Kernan, N.; Small, T.; Van Syckle, K.; Williams, T.; Yahalom, J.; O'Reilly, R.
    Blood (1996)

    Fulltext@MSK | Save